The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Pyridine-3-sulfonic acid [2,4-difluoro-3-(5-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-phenyl]-amide ID: ALA3977421
PubChem CID: 49779244
Max Phase: Preclinical
Molecular Formula: C20H14F2N4O3S
Molecular Weight: 428.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cnc2[nH]cc(C(=O)c3c(F)ccc(NS(=O)(=O)c4cccnc4)c3F)c2c1
Standard InChI: InChI=1S/C20H14F2N4O3S/c1-11-7-13-14(10-25-20(13)24-8-11)19(27)17-15(21)4-5-16(18(17)22)26-30(28,29)12-3-2-6-23-9-12/h2-10,26H,1H3,(H,24,25)
Standard InChI Key: UPHZYLHTKYNCFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
7.4084 -8.1141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4125 -8.9313 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1181 -8.5192 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5422 -8.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5410 -9.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2491 -9.7388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2473 -8.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9559 -8.5067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9607 -9.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7451 -9.5797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2251 -8.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7369 -8.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1409 -7.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9581 -7.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7277 -6.8328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3685 -8.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1849 -8.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5897 -7.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1721 -6.8153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3571 -6.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9631 -8.9480 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.9410 -6.1204 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5977 -8.9388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8277 -9.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4215 -10.3467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8337 -11.0514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6518 -11.0470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0559 -10.3318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6414 -9.6300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8344 -8.1019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
16 21 1 0
20 22 1 0
17 23 1 0
23 2 1 0
2 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
4 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 428.42Molecular Weight (Monoisotopic): 428.0755AlogP: 3.58#Rotatable Bonds: 5Polar Surface Area: 104.81Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.96CX Basic pKa: 3.24CX LogP: 2.75CX LogD: 2.66Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -1.52
References 1. (2012) Compounds and methods for kinase modulation, and indications thereof,